RT-100 delivers a gene directly into heart muscle cells, restoring an enzyme those cells lose as heart failure progresses and rebuilding the cell's ability to respond to its own signals. It is given through a catheter into the coronary arteries, because the gene only works in the cells it reaches.
RT-100 is for heart failure with reduced ejection fraction, where the heart has weakened and no longer squeezes forcefully enough, and where the goal is to restore the pumping cell itself.